|
Sqz Biotechnologies Company (SQZB) |
|
Sqz Biotechnologies Company
SQZB's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Sqz Biotechnologies's sales fell
in III. Quarter 2023 from the same quarter a year ago.
Biotechnology & Pharmaceuticals industry recorded
deterioration of revenues by -8 %
• More on SQZB's Growth
|
|
Sqz Biotechnologies realized a net loss in trailing twelve months.
Sqz Biotechnologies realized cash reduction of $ -2.51 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.07.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.38.
• More on SQZB's Valuation
|
|
|
|
|
Sqz Biotechnologies realized net loss in trailing twelve months.
Sqz Biotechnologies realized cash outflow of $ -2.51per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.07.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.38.
Sqz Biotechnologies Price to Book Ratio is at 0.44 higher than Industry Avg. of -0, and higher than S&P 500 Avg. of 0.01
• More on SQZB's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2024 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com